drugset / Trial / NCT01461083
Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a
NaSingle-groupOpen-label
Summary
The underlying goal of this study is to assess \[18F\]MPPF PET imaging as a tool to evaluate the activity of the serotonin 5HT1a receptor in the brain of Parkinson Disease (PD) research participants.
Timeline
- Start
- 2011-09
- Primary completion
- 2012-11
- Completion
- 2014-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [18F]MPPF | Unknown | 185 mbq | Intravenous |